Idogen AB Employee Directory

Biotechnology ResearchGävleborg, Sweden11-50 Employees

Idogen AB is a biotechnology research company focused on developing tolerogenic cell therapies that re-program the immune system to tolerate specific molecules after treatment. This approach aims to address conditions such as autoimmune diseases, organ rejection after transplantation, and immune responses against standard therapies, with initial work targeting hemophilia A patients who have developed inhibitors to factor VIII. The companyʼs therapy involves reprogramming a patient’s blood-derived cells into dendritic cells capable of counteracting unwanted immune reactions, offering potential long-acting treatment for anti-drug antibodies and other immune-related disorders. Based in Lund, Sweden, Idogen was founded in 2008 and operates within the biotechnology research sector, seeking to shift transplant and immunotherapy paradigms by reducing reliance on broad immunosuppression and enabling more targeted immune tolerance.

Sign up for free to view info

Company overview Email format